Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
04/2004
04/07/2004EP1404279A2 Mutant forms of cholera holotoxin as an adjuvant
04/07/2004EP1404179A2 Novel biofungicide
04/07/2004EP1124843B1 Low allergenic protein variants
04/07/2004EP0901520B1 Culture medium for revealing enterohaemorragic e. coli bacteria and procedure therefor
04/07/2004EP0854914B1 Live vaccines against gram-negative pathogens, expressing heterologous o-antigens
04/07/2004EP0817781B1 Alkali metal formononetin and method of mycorrhizal stimulation
04/07/2004CN1487994A Solid culture medium and method for preparing the same
04/07/2004CN1487953A Recepter in the EDb Fibronection domain
04/07/2004CN1487860A Organic waste fermentatively-processing device
04/07/2004CN1487798A Combination of probiotics
04/07/2004CN1487086A Purification method of recombinant yeast strain and rhGM-CSF to express human granulocyte-macrophage colony stimulating factor
04/07/2004CN1487083A Rockfish insulin-like growth factor Ôàí gene, carrier and recombinant strain containing the gene and their application
04/07/2004CN1487079A Fermentation production process for phosphoglyceric acid family amino-acid and amino-acid derivative
04/07/2004CN1487078A Lactobacillus cell microcyst culturing process and produced leaven
04/07/2004CN1487077A Culture process of SARS virus resisting fungus
04/07/2004CN1487070A Tomato beverage and yeast for preparing the beverage
04/07/2004CN1144876C Process for producing cis-3-hydroxy-L-proline
04/07/2004CN1144873C Clostridium butyricum and its use
04/07/2004CN1144815C Modified i CE.(oli) enterotoxin II signal peptide and microorganism expressing fusion protein of said peptide and heterologous protein
04/06/2004US6716965 Adipocyte complement related protein zacrp13
04/06/2004US6716818 Caspase inhibitors and the use thereof
04/06/2004US6716623 Compositions and methods for identifying antigens which elicit an immune response
04/06/2004US6716617 Fermentation method with continuous mass cultivation of ciliates (protozoa) for producing biogenous valuable substances
04/06/2004US6716609 Enzymatic polypeptide for use in the generation of 2-pyrone-4,6-dicarboxylic acid
04/06/2004US6716608 Artificial chromosome
04/06/2004US6716602 Metabolic rate shifts in fermentations expressing recombinant proteins
04/06/2004US6716601 Controlling the expression of homologous and heterologous nucleic acid molecules in yeast cells.
04/06/2004US6716575 Diagnosis and treatment of AUR1 and/or AUR2 related disorders
04/06/2004US6716474 Expression of fructose 1,6 bisphosphate aldolase in transgenic plants
04/06/2004US6716430 Moderating immunology response
04/06/2004CA2269077C Keratinocyte growth factor-2 products
04/06/2004CA2196296C Production of tissue factor pathway inhibitor
04/06/2004CA2194685C A method of improving the quality of plant seeds
04/06/2004CA2085232C Xylanase production
04/06/2004CA2042016C Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis
04/06/2004CA2010321C Lymphocyte-associated cell surface protein
04/01/2004WO2004027067A2 Methods for increasing the production of a recombinant polypeptide from a host cell
04/01/2004WO2004027057A1 Method of analyzing organelle-localized protein and materials for analysis
04/01/2004WO2004027055A1 Novel carbonyl reductase, gene thereof and method of using the same
04/01/2004WO2004027021A2 Device and methods for isolating target cells
04/01/2004WO2004027018A2 Inducible focal adhesion kinase cell assay
04/01/2004WO2004026907A2 Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals
04/01/2004WO2004026901A1 M. paratuberculosis specific abc-transporter operon
04/01/2004WO2004026891A2 Protein purification
04/01/2004WO2004026254A2 Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b
04/01/2004WO2004018681A3 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof
04/01/2004WO2004010103A3 Impedance based devices and methods for use in assays
04/01/2004WO2004009762A9 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof
04/01/2004WO2004007723A3 Genes
04/01/2004WO2004005473A3 Hcv fusion proteins with modified ns3 domains
04/01/2004WO2003097825A3 Novel phospholipases and uses thereof
04/01/2004WO2003093461A3 Genomic library of cyanophage s-2l and functional analysis
04/01/2004WO2003092628A3 High-quality lipids and methods for producing by enzymatic liberation from biomass
04/01/2004WO2003077868A3 Synthesis of synthons for the manufacture of bioactive compounds
04/01/2004WO2003073828A3 Immunotherapy for prostate cancer using recombinant bacille calmette-guerin expressing prostate specific antigens
04/01/2004WO2003070907A3 Novel fungal lipase
04/01/2004WO2003066877A3 Compositions and methods relating to hepatic specific genes and proteins
04/01/2004WO2003062270B1 Fluorescent protein from aequorea coerulscens and uses therof
04/01/2004WO2003050283A3 A structure for presenting desired peptide sequences
04/01/2004WO2003046201A3 Detection and identification of enteric bacteria
04/01/2004WO2003045990A3 Protein-protein interactions involving transforming growth factor beta signalling
04/01/2004WO2003040180A3 Genes of corynebacterium glutamicum encoding for genetic stability, gene expression and folding proteins
04/01/2004WO2003031940A3 Structural and cytoskeleton-associated proteins
04/01/2004WO2003020885A9 Identification of sortase gene
04/01/2004WO2003014161A9 Antigen binding domains from fish
04/01/2004WO2003012044A9 Hagfish cathelin-associated antimicrobial peptides and genes
04/01/2004WO2002083847A3 Cdna encoding the human alpha2 delta4 calcium channel subunit
04/01/2004WO2002081676A3 Non-pathogenic bacterial recipient strain of a bacterium containing mycolic acid, method for the production thereof and use of the same
04/01/2004WO2002072777A9 A novel antagonistic yeast useful in controlling spoilage of agricultural produce, methods of use thereof and compositions containing same
04/01/2004WO2002064631A3 T1r taste receptors and genes encoding same
04/01/2004WO2002059377A3 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
04/01/2004US20040064857 Using agrobacterium to generate transgenic sterility controllable plant model for monitoring heterologous gene expression; tissue engineering
04/01/2004US20040064853 Expression vector coding fructosyltransferase for generation of disease and insect resistant plants
04/01/2004US20040064848 Comprises nucleotide sequences coding dehydroquinase/shikimate dehydrogenase for use in high throughput assay which detects herbicides
04/01/2004US20040064842 Using dispersed regulatory nucleotide sequences to regulate transcription in animal cells, tissues and/or organs; gene expression inhibition
04/01/2004US20040063923 Molecular differences between species of the M. tuberculosis complex
04/01/2004US20040063909 Comprises nucleotide sequences coding membrane proteins for treatment and diagnosis cell proliferative, inflammatory, autoimmune and nervous system disorders
04/01/2004US20040063908 Comprises genetically engineered hemophilus adherence and penetration (HAP) proteins for treatment and prevention of influenza; immunotherapy
04/01/2004US20040063907 Gene differentially expressed in breast and bladder cancer and encoded polypeptides
04/01/2004US20040063207 Recombinational cloning using nucleic acids having recombination sites
04/01/2004US20040063200 Biological component comprising artificial membrane
04/01/2004US20040063192 Using sulfur dioxide to decrease concentration of carbon dioxide and ethanol produced in industrial steeping process
04/01/2004US20040063191 Compositions and methods for determining the replication capacity of a pathogenic virus
04/01/2004US20040063190 Preparation and usage of plasmodium fusion antigen
04/01/2004US20040063181 Process for the preparation of L-amino acids using a gene encoding 6-phosphogluconate dehydrogenase
04/01/2004US20040063180 Comprises nucleotide sequences coding lysine biosynthetic polypeptide for transforming coryneform bacteria and fermentation of lysine; animal feeds and medicine
04/01/2004US20040063177 Generating subtilisin mutant with decreased immunogenicity for use in laundry detergents, cosmetics and textile treatment
04/01/2004US20040063175 Transgenic cell for preparation of monatin; food and beverage sweetening
04/01/2004US20040063171 Genetic engineered microroganisms; auxotropic mutants; polynucleotide sequences
04/01/2004US20040063145 Transcription factor comprising bromodomain for diagnosis and treatment of leukemia
04/01/2004US20040063143 Comprises nucleotide sequences coding enzymatic polypeptides associated with steroid, carotenoids and squalene biosynthesis
04/01/2004US20040063142 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof
04/01/2004US20040063140 Methods for diagnosis of cancer using erbB-3
04/01/2004US20040063139 Comprises using nucleotide sequences coding deoxyguanosine triphosphate triphosphophydrolase to detect microorganisms in water supply
04/01/2004US20040063135 Comprises oligonucleotides for determining concentration of glucuonidase in cell culture; detection and monitoring of malignancies and metastasis; targeted drug delivery
04/01/2004US20040063134 Novel isoforms of human pregnancy-associated protein-E
04/01/2004US20040063131 Comprises neuroendocrine-specific proteins-like polypeptides (NSPLP) for diagnosis, prevention and treatment of neurodegenerative and cell proliferative diseases
04/01/2004US20040063127 Comprises nuclelotide sequences coding cytokine for diagnosis, prevention and treatment of infection, hepatitis, nephritis, cancer and autoimmune diseases
04/01/2004US20040063125 Transgenic cells coding membrane protein which controls intracellular hydrogen ion concentration for identifying modulators for treatment of diabetes
04/01/2004US20040063124 Methods and apparatus for preparing and assaying biological samples to determine protein concentration